Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Pulmonary toxicity due to amiodarone]

A Politi1, M Galli, G Ferrari

  • 1Divisione di Cardiologia, Ospedale S Anna, Como.

Cardiologia (Rome, Italy)
|February 1, 1993
PubMed
Summary

Amiodarone treatment for ventricular arrhythmias can cause pulmonary toxicity in patients with coronary heart disease. Two cases illustrate distinct presentations and recovery patterns, highlighting potential management challenges.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Combined duodenal and pancreatic major trauma in high risk patients: can a partial reconstruction be safe?

Minerva chirurgica·2014
Same author

On-chip manipulation of single photons from a diamond defect.

Physical review letters·2013
Same author

How does illness severity influence depression, health satisfaction and life satisfaction in patients with cardiovascular disease? The mediating role of illness perception and self-efficacy beliefs.

Psychology & health·2013
Same author

A dynamical approach to protein folding.

Journal of biological physics·2013
Same author

Pancreatic injury in a blunt abdominal trauma treated by a conservative approach with Tachosil®.

Minerva chirurgica·2012
Same author

Collective atomic recoil laser as a synchronization transition.

Physical review. E, Statistical, nonlinear, and soft matter physics·2008

Area of Science:

  • Cardiology
  • Pulmonology
  • Pharmacology

Background:

  • Amiodarone is a widely used antiarrhythmic drug for managing ventricular arrhythmias.
  • Coronary heart disease and prior myocardial infarction are common comorbidities in patients requiring amiodarone therapy.
  • Pulmonary toxicity is a known but variable adverse effect of amiodarone.

Observation:

  • Two patients with coronary heart disease and a history of myocardial infarction developed amiodarone-induced pulmonary toxicity.
  • Patient 1 exhibited interstitial infiltrates resolving over 2 months with steroid therapy after 1 year of amiodarone (300 mg/day).
  • Patient 2 showed pulmonary edema, resolving rapidly without steroids after 4 months (200 mg/day) and 3 weeks (400 mg/day) of amiodarone.

Findings:

  • The study identified two distinct patterns of amiodarone-induced pulmonary toxicity.
  • Resolution times and response to steroid therapy varied between the two observed cases.
  • Management of refractory ventricular arrhythmias post-amiodarone withdrawal proved challenging in one patient.

Implications:

  • Early recognition of amiodarone pulmonary toxicity is crucial for timely drug withdrawal.
  • Distinct clinical presentations may necessitate tailored management strategies, including the judicious use of steroids.
  • The potential for difficult-to-manage arrhythmias after amiodarone cessation requires careful consideration.

Related Experiment Videos